InflaRx N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IFRX research report →
About the company
InflaRx N. V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel inhibitors leveraging C5a technology, primarily operating in Germany and the United States.
- CEO
- Niels C. Riedemann
- IPO
- 2017
- Employees
- 74
- HQ
- Jena, DE
Price Chart
- Market Cap
- $161.80M
- P/E
- -3.22
- P/S
- 4822.49
- P/B
- 3.83
- EV/EBITDA
- -3.00
- Div Yield
- 0.00%
- Gross Margin
- -24646.27%
- Op Margin
- -144444.96%
- Net Margin
- -146303.92%
- ROE
- -94.90%
- ROIC
- -112.11%
- Revenue
- $29.33K · -82.31%
- Net Income
- $-45,633,780 · 0.93%
- EPS
- $-0.66 · 15.38%
- Op Income
- $-48,256,974
- FCF YoY
- 29.98%
- 52W High
- $2.95
- 52W Low
- $0.74
- 50D MA
- $2.10
- 200D MA
- $1.36
- Beta
- 2.46
- Avg Volume
- 2.02M
Get TickerSpark's AI analysis on IFRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Kubler Mark | other | 0 |
| Mar 18, 26 | Kubler Mark | other | 7,308 |
| Mar 18, 26 | Kubler Mark | other | 30,000 |
| Mar 18, 26 | Kubler Mark | other | 30,000 |
| Mar 18, 26 | Kubler Mark | other | 30,000 |
| Mar 18, 26 | Kubler Mark | other | 30,000 |
| Mar 18, 26 | Kubler Mark | other | 30,000 |
| Mar 18, 26 | Gibney Anthony S | other | 0 |
| Mar 18, 26 | Gibney Anthony S | other | 30,000 |
| Mar 18, 26 | Gibney Anthony S | other | 30,000 |
Our IFRX coverage
Recent articles, reports, and earnings notes.
No research on IFRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IFRX report →Similar companies
Peers in the same neighborhood.